Cystathionine β-synthase (CBS) is essential for homocysteine (Hcy) transsulfuration, yielding cysteine as a common precursor of hydrogen sulfide (H2S), glutathione (GSH), and other sulfur molecules, which produce neuroprotective effects in neurological conditions. We previously reported a disruption of microglial CBS/H2S signaling in a Parkinson's disease (PD) mouse model. Yet, it remains unclear whether CBS affects nucleotide-binding oligomerization domain, leucine-rich repeat and pyrin domain-containing 3 (NLRP3) inflammasome activity and other pathologies in PD.
Results:
Microglial CBS expression decreased after lipopolysaccharide (LPS) stimulation. Elevated GSSG (the oxidized GSH) content and decreased H2S generation were found in the brains of microglial cbs conditional-knockout (cbscKO) mice, whereas serum and brain Hcy levels remained unaltered. Moreover, microglial cbscKO mice were susceptible to NLRP3 inflammasome activation and dopaminergic neuron losses caused by LPS injection into the substantia nigra, whereas cbs overexpression or activation produced opposite effects. In vitro studies showed that cbs overexpression or activation suppressed microglial NLRP3 inflammasome activation and interleukin (IL)-1β secretion by reducing mitochondrial reactive oxygen species (mitoROS) level. Conversely, ablation of cbs enhanced NLRP3 expression and mitoROS generation and augmented microglial NLRP3 inflammasome activity in response to adenosine triphosphate challenge, which was blocked by the mitoROS scavenger.
Innovation and Conclusion:
The study demonstrated an elevated GSSG level and reduced H2S generation, which correlated with a susceptible status of microglia in the brain of cbscKO mice. Our findings reveal a critical role of CBS in restraining the microglial NLRP3 inflammasome by controlling redox homeostasis and highlight that activation or upregulation of CBS may become a potential strategy for PD treatment.
Get full access to this article
View all access options for this article.
References
1.
BaeSK, HeoCH, ChoiDJ, et al.A ratiometric two-photon fluorescent probe reveals reduction in mitochondrial H2S production in Parkinson's disease gene knockout astrocytes. J Am Chem Soc, 2013; 135(26):9915–9923; doi: 10.1021/ja404004v
CarveyPM, ChenEY, LiptonJW, et al.Intra-parenchymal injection of tumor necrosis factor-alpha and interleukin 1-beta produces dopamine neuron loss in the rat. J Neural Transm (Vienna), 2005; 112(5):601–612; doi: 10.1007/s00702-004-0222-z
4.
CastelblancoM, LugrinJ, EhirchiouD, et al.Hydrogen sulfide inhibits NLRP3 inflammasome activation and reduces cytokine production both in vitro and in a mouse model of inflammation. J Biol Chem, 2018; 293(7):2546–2557; doi: 10.1074/jbc.M117.806869
5.
ChenC, WeiYZ, HeXM, et al.Naringenin produces neuroprotection against LPS-induced dopamine neurotoxicity via the inhibition of microglial NLRP3 inflammasome activation. Front Immunol, 2019; 10:936; doi: 10.3389/fimmu.2019.00936
DuC, JinM, HongY, et al.Downregulation of cystathionine beta-synthase/hydrogen sulfide contributes to rotenone-induced microglia polarization toward M1 type. Biochem Biophys Res Commun, 2014; 451(2):239–245; doi: 10.1016/j.bbrc.2014.07.107
8.
EngelborghsS, MarescauB, De DeynPP. Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease. Neurochem Res, 2003; 28(8):1145–1150; doi: 10.1023/a:1024255208563
9.
EnokidoY, SuzukiE, IwasawaK, et al.Cystathionine beta-synthase, a key enzyme for homocysteine metabolism, is preferentially expressed in the radial glia/astrocyte lineage of developing mouse CNS. FASEB J, 2005; 19(13):1854–1856; doi: 10.1096/fj.05-3724fje
10.
GordonR, AlbornozEA, ChristieDC, et al.Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice. Sci Transl Med, 2018; 10(465):eaah4066; doi: 10.1126/scitranslmed.aah4066
11.
HanX, XuT, FangQ, et al.Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy. Redox Biol, 2021; 44:102010; doi: 10.1016/j.redox.2021.102010
12.
HeJ, ZhuG, WangG, et al.Oxidative stress and neuroinflammation potentiate each other to promote progression of dopamine neurodegeneration. Oxid Med Cell Longev, 2020; 2020:6137521; doi: 10.1155/2020/6137521
13.
HeY, FranchiL, NúñezG. TLR agonists stimulate Nlrp3-dependent IL-1β production independently of the purinergic P2X7 receptor in dendritic cells and in vivo. J Immunol, 2013; 190(1):334–339; doi: 10.4049/jimmunol.1202737
14.
HuLF, LuM, Hon WongPT, et al.Hydrogen sulfide: Neurophysiology and neuropathology. Antioxid Redox Signal, 2011; 15(2):405–419; doi: 10.1089/ars.2010.3517
15.
HuLF, LuM, TiongCX, et al.Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models. Aging Cell, 2010; 9(2):135–146; doi: 10.1111/j.1474-9726.2009.00543.x
16.
HuLF, WongPT, MoorePK, et al.Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. J Neurochem, 2007; 100(4):1121–1128; doi: 10.1111/j.1471-4159.2006.04283.x
17.
JakariaM, AzamS, HaqueME, et al.Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms. Redox Biol, 2019; 24:101223; doi: 10.1016/j.redox.2019.101223
18.
JheeKH, KrugerWD. The role of cystathionine beta-synthase in homocysteine metabolism. Antioxid Redox Signal, 2005; 7(5–6):813–822; doi: 10.1089/ars.2005.7.813
19.
JiaJ, WangZ, ZhangM, et al.SQR mediates therapeutic effects of H2S by targeting mitochondrial electron transport to induce mitochondrial uncoupling. Sci Adv, 2020; 6(35):eaaz5752; doi: 10.1126/sciadv.aaz5752
20.
KidaK, YamadaM, TokudaK, et al.Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson's disease. Antioxid Redox Signal, 2011; 15(2):343–352; doi: 10.1089/ars.2010.3671
21.
KimSY, JinCY, KimCH, et al.Isorhamnetin alleviates lipopolysaccharide-induced inflammatory responses in BV2 microglia by inactivating NF-κB, blocking the TLR4 pathway and reducing ROS generation. Int J Mol Med, 2019; 43(2):682–692; doi: 10.3892/ijmm.2018.3993
22.
LeeE, HwangI, ParkS, et al.MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. Cell Death Differ, 2019; 26(2):213–228; doi: 10.1038/s41418-018-0124-5
23.
MaoZ, LiuC, JiS, et al.The NLRP3 inflammasome is involved in the pathogenesis of Parkinson's disease in rats. Neurochem Res, 2017; 42(4):1104–1115; doi: 10.1007/s11064-017-2185-0
24.
MustafaAK, GadallaMM, SenN, et al.H2S signals through protein S-sulfhydration. Sci Signal, 2009; 2(96):ra72; doi: 10.1126/scisignal.2000464
25.
NagarA, RahmanT, HartonJA. The ASC Speck and NLRP3 inflammasome function are spatially and temporally distinct. Front Immunol, 2021; 12:752482; doi: 10.3389/fimmu.2021.752482
26.
PanagakiT, Lozano-MontesL, JanickovaL, et al.Overproduction of hydrogen sulfide, generated by cystathionine beta-synthase, disrupts brain wave patterns and contributes to neurobehavioral dysfunction in a rat model of Down syndrome. Redox Biol, 2022; 51:102233; doi: 10.1016/j.redox.2022.102233
27.
QiaoC, ZhangLX, SunXY, et al.Caspase-1 deficiency alleviates dopaminergic neuronal death via inhibiting caspase-7/AIF pathway in MPTP/p mouse model of Parkinson's disease. Mol Neurobiol, 2017; 54(6):4292–4302; doi: 10.1007/s12035-016-9980-5
28.
QiaoC, ZhangQ, JiangQ, et al.Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson's disease. J Neuroinflammation, 2018; 15(1):193; doi: 10.1186/s12974-018-1236-z
29.
RobertK, NehmeJ, BourdonE, et al.Cystathionine beta synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver. Gastroenterology, 2005; 128(5):1405–1415; doi: 10.1053/j.gastro.2005.02.034
30.
RobertK, VialardF, ThieryE, et al.Expression of the cystathionine beta synthase (CBS) gene during mouse development and immunolocalization in adult brain. J Histochem Cytochem, 2003; 51(3):363–371; doi: 10.1177/002215540305100311
31.
RojoAI, McBeanG, CindricM, et al.Redox control of microglial function: Molecular mechanisms and functional significance. Antioxid Redox Signal, 2014; 21(12):1766–1801; doi: 10.1089/ars.2013.5745
32.
SasakuraK, HanaokaK, ShibuyaN, et al.Development of a highly selective fluorescence probe for hydrogen sulfide. J Am Chem Soc, 2011; 133(45):18003–18005; doi: 10.1021/ja207851s
33.
SbodioJI, SnyderSH, PaulBD. Regulators of the transsulfuration pathway. Br J Pharmacol, 2019; 176(4):583–593; doi: 10.1111/bph.14446
34.
ShanH, QiuJ, ChangP, et al.Exogenous hydrogen sulfide offers neuroprotection on intracerebral hemorrhage injury through modulating endogenous H2S metabolism in mice. Front Cell Neurosci, 2019; 13:349; doi: 10.3389/fncel.2019.00349
35.
ShibuyaN, TanakaM, YoshidaM, et al.3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal, 2009; 11(4):703–714; doi: 10.1089/ars.2008.2253
36.
TeleanuDM, NiculescuAG, LunguII, et al.An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases. Int J Mol Sci, 2022; 23(11):5938; doi: 10.3390/ijms23115938
37.
TuHY, YuanBS, HouXO, et al.Alpha-synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson's disease. Aging Cell, 2021; 20(12):e13522; doi: 10.1111/acel.13522
38.
VandiverMS, PaulBD, XuR, et al.Sulfhydration mediates neuroprotective actions of parkin. Nat Commun, 2013; 4:1626; doi: 10.1038/ncomms2623
39.
VitvitskyV, DayalS, StablerS, et al.Perturbations in homocysteine-linked redox homeostasis in a murine model for hyperhomocysteinemia. Am J Physiol Regul Integr Comp Physiol, 2004; 287(1):R39–R46; doi: 10.1152/ajpregu.00036.2004
40.
von HerrmannKM, SalasLA, MartinezEM, et al.NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson's disease. NPJ Parkinsons Dis, 2018; 4:24; doi: 10.1038/s41531-018-0061-5
41.
YanX, HeM, HuangH, et al.Endogenous H2S targets mitochondria to promote continual phagocytosis of erythrocytes by microglia after intracerebral hemorrhage. Redox Biol, 2022; 56:102442; doi: 10.1016/j.redox.2022.102442
42.
YanY, JiangW, LiuL, et al.Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell, 2015; 160(1–2):62–73; doi: 10.1016/j.cell.2014.11.047
43.
YuanYQ, WangYL, YuanBS, et al.Impaired CBS-H2S signaling axis contributes to MPTP-induced neurodegeneration in a mouse model of Parkinson's disease. Brain Behav Immun, 2018; 67:77–90; doi: 10.1016/j.bbi.2017.07.159
44.
ZhangM, ShanH, WangT, et al.Dynamic change of hydrogen sulfide after traumatic brain injury and its effect in mice. Neurochem Res, 2013; 38(4):714–725; doi: 10.1007/s11064-013-0969-4
45.
ZhangM, WuX, XuY, et al.The cystathionine beta-synthase/hydrogen sulfide pathway contributes to microglia-mediated neuroinflammation following cerebral ischemia. Brain Behav Immun, 2017; 66:332–346; doi: 10.1016/j.bbi.2017.07.156
46.
ZhangP, ShaoXY, QiGJ, et al.Cdk5-dependent activation of neuronal inflammasomes in Parkinson's disease. Mov Disord, 2016; 31(3):366–376; doi: 10.1002/mds.26488
47.
ZhaoH, PanP, YangY, et al.Endogenous hydrogen sulphide attenuates NLRP3 inflammasome-mediated neuroinflammation by suppressing the P2X7 receptor after intracerebral haemorrhage in rats. J Neuroinflammation, 2017; 14(1):163; doi: 10.1186/s12974-017-0940-4
48.
ZhouR, YazdiAS, MenuP, et al.A role for mitochondria in NLRP3 inflammasome activation. Nature, 2011; 469(7329):221–225; doi: 10.1038/nature09663
49.
ZhouY, LuM, DuRH, et al.MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease. Mol Neurodegener, 2016; 11:28; doi: 10.1186/s13024-016-0094-3
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
